Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- معلومة اضافية
- المصدر:
Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
- بيانات النشر:
Original Publication: [London] : BioMed Central, 2006-
- الموضوع:
- نبذة مختصرة :
Background: Recruitment of sufficient participants in an efficient manner is still widely acknowledged to be a major challenge to the mounting and completion of randomised controlled trials (RCTs). Few recruitment interventions have involved staff undertaking recruitment. This study aimed i) to understand the recruitment process from the perspective of recruiters actively recruiting RCT participants in six pragmatic RCTs, and ii) to identify opportunities for interventions to improve recruitment.
Methods: Interviews were undertaken with 72 individuals (32 doctors or RCT Chief investigators (CIs); 40 nurses/other health professionals) who were actively recruiting participants in six RCTs to explore their experiences of recruitment. The RCTs varied in scale, duration, and clinical contexts. Interviews were fully transcribed and analysed using qualitative content and thematic analytic methods derived from grounded theory. For this analysis, data were systematically extracted from each RCT and synthesised across all six RCTs to produce a detailed and nuanced understanding of the recruitment process from the perspectives of the recruiters.
Results: Recruiters readily identified organisational difficulties, fewer than expected eligible patients, and patients' treatment preferences as the key barriers to recruitment. As they described their experiences of recruitment, several previously hidden issues related to their roles as researchers and clinicians emerged, imbued with discomfort and emotion. The synthesis across the RCTs showed that doctors were uncomfortable about aspects of patient eligibility and the effectiveness of interventions, whereas nurses were anxious about approaching potential RCT participants and conflicts between the research and their clinical responsibilities. Recruiters seemed unaware that their views contributed to recruitment difficulties. Their views were not known to RCT CIs. Training and support needs were identified for both groups of staff.
Conclusions: The synthesis showed that recruitment to these RCTs was a complex and fragile process. Clear obstacles were identified but hidden challenges related to recruiters' roles undermined recruitment, unbeknown to RCT CIs. Qualitative research can elicit and identify the hidden challenges. Training and support are then needed for recruiters to become more comfortable with the design and principles of RCTs, so that they can engage more openly with potentially eligible participants and create a more resilient recruitment process.
- References:
Contemp Clin Trials. 2008 Sep;29(5):663-70. (PMID: 18479977)
Eur Arch Otorhinolaryngol. 2013 Aug;270(8):2333-7. (PMID: 23334205)
N Engl J Med. 1987 Jul 16;317(3):141-5. (PMID: 3600702)
J Adv Nurs. 2002 Mar;37(5):439-45. (PMID: 11843982)
N Engl J Med. 2011 Feb 3;364(5):476-80. (PMID: 21288100)
Soc Sci Med. 2012 Feb;74(4):574-81. (PMID: 22236642)
J Clin Epidemiol. 2001 Sep;54(9):877-83. (PMID: 11520646)
Clin Trials. 2004;1(2):170-8. (PMID: 16281889)
Health Technol Assess. 2007 Nov;11(48):iii, ix-105. (PMID: 17999843)
JAMA. 2005 Mar 2;293(9):1089-99. (PMID: 15741531)
J Clin Nurs. 2008 Feb;17(4):549-57. (PMID: 17419791)
Int Nurs Rev. 2007 Mar;54(1):41-8. (PMID: 17305956)
Lancet. 2002 Feb 23;359(9307):650-6. (PMID: 11879860)
J Clin Epidemiol. 2011 Oct;64(10):1127-36. (PMID: 21477994)
Nurs Ethics. 2008 Nov;15(6):803-12. (PMID: 18849369)
Ann Intern Med. 2003 Apr 15;138(8):669-72. (PMID: 12693890)
Clin Trials. 2012 Oct;9(5):621-7. (PMID: 22777654)
Contemp Clin Trials. 2009 Jan;30(1):40-6. (PMID: 18718555)
Br Med J. 1963 Apr 20;1(5337):1043-9. (PMID: 13954493)
Trials. 2006 May 17;7:16. (PMID: 16707011)
Health Expect. 2014 Oct;17(5):670-82. (PMID: 22712887)
Soc Sci Med. 2005 Aug;61(3):685-95. (PMID: 15899326)
Control Clin Trials. 1987 Dec;8(4 Suppl):6S-30S. (PMID: 3326716)
Trials. 2011 Mar 15;12:78. (PMID: 21406089)
Trials. 2006 Apr 07;7:9. (PMID: 16603070)
Cochrane Database Syst Rev. 2010 Jan 20;(1):MR000013. (PMID: 20091668)
J Clin Epidemiol. 2009 Jan;62(1):29-36. (PMID: 18619811)
J Clin Epidemiol. 1999 Dec;52(12):1143-56. (PMID: 10580777)
- Grant Information:
United Kingdom WT_ Wellcome Trust; 09/127/53 United Kingdom DH_ Department of Health; MC_U145079312 United Kingdom MRC_ Medical Research Council; G0800800 United Kingdom MRC_ Medical Research Council; United Kingdom CRUK_ Cancer Research UK
- الموضوع:
Date Created: 20140108 Date Completed: 20140915 Latest Revision: 20220408
- الموضوع:
20221213
- الرقم المعرف:
PMC3892115
- الرقم المعرف:
10.1186/1745-6215-15-5
- الرقم المعرف:
24393291
No Comments.